NICE backs new oral MS drug, Gilenya
NICE backs new oral MS drug, Gilenya
Novartis's multiple sclerosis pill Gilenya has been recommended for use on the U.K.'s publicly-funded National Health Service after a change of heart by the country's healthcare cost-effectiveness watchdog.
Friday's verdict from the National Institute for Health and Clinical Excellence, whose opinions are also watched closely in other countries, is welcome news for the Swiss company's potential blockbuster product whose safety profile has come into question recently.
NICE said it changed its mind on the medicine, also knows as fingolimod, after Novartis provided more information and analyses on the pill, allowing the British agency to compare the medicine's performance with existing injectable MS therapies.... Read More -
http://www.msrc.co.uk/index.cfm/fuseact ... geid/1309/
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 1 Replies
- 900 Views
-
Last post by NHE
-
- 1 Replies
- 1140 Views
-
Last post by Petr75
-
- 0 Replies
- 16 Views
-
Last post by NHE
-
- 5 Replies
- 14255 Views
-
Last post by gibbledygook
-
- 0 Replies
- 494 Views
-
Last post by NHE
-
- 0 Replies
- 1668 Views
-
Last post by NHE
-
- 1 Replies
- 3142 Views
-
Last post by Tif
-
- 2 Replies
- 1073 Views
-
Last post by DIM
-
- 1 Replies
- 1991 Views
-
Last post by raceya